iPremom
iPremom is a healthcare technology company that develops molecular diagnostics for the early detection of pregnancy complications.
$17.37M Seed ·
Led by Amadeus Capital Partners · Source: finsmes.com
Funding history ↓Signals
Website registeredJul 1, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $17.37M | finsmes.com |
Timeline
- Website created
Investors
Companies like iPremom
TTvaster Genkalp$1.25M Series A · Apr 2025
EEn Carta DiagnosticsSeed · Jul 2026
CCanopie$3.7M Seed · Sep 2024MMirvie$60M Series B+ · May 2022
KKalia Health
PProov$9.7M Series B+ · Dec 2021
Other companies backed by Amadeus Capital Partners
IiPronics$121.11M Series B+ · Nov 2026
TTenzo$5M Series A · Apr 2026
CCreditas$108M Series B+ · Dec 2025
SSitehop$10M Series A · Oct 2025
QQUIBIM$50M Series A · Feb 2025
CConstructive Bio$58M Series A · Sep 2024
Amadeus Capital Partners portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ipremom (get a free API key).